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Purpose: We examined the postoperative visual recovery and quality of life after retinal
detachment (RD) surgery.
Methods: In addition to a baseline clinical examination, patients filled out the National Eye
Institute Visual Functioning Questionnaire at three time points: preoperatively and 1 and 3
months postoperatively (M1 and M3, respectively). We analyzed the composite score and
short-form scores (socioemotional scale [SFSES] and visual functioning scale [SFVFS]).
Results: One hundred ninety-four patients were enrolled in this study; 47 (26 macula-ON
RD and 21 macula-OFF RD) returned all three questionnaires. The best corrected visual
acuity was Snellen equivalent 20/25, 20/25, and 20/20 at the preoperative, M1, and M3
assessment, respectively. At M3, we found a positive correlation between SFSES and best
corrected visual acuity measures among macula-OFF patients (P , 0.001, R2 = 0.58). A
significant correlation with the best corrected visual acuity among macula-ON patients was
observed only at M3 with the SFVFS score (P , 0.001, R2 = 0.41).
Conclusion: The quality of life differs between ON and OFF RD in regard to the
composite score and especially SFSES and SFVFS. We found a transient decrease in the
quality of life at M1 for macula-ON patients, whereas the quality of life improved throughout
follow-up among macula-OFF patients. These data may help improve the management of
patients’ expectations after RD surgery.
RETINA 41:653–660, 2021
After surgery for rhegmatogenous retinal detachment(RD), the retina will be reattached in 95% of treated
patients, with useful vision retained in most cases.1–4
Surgical success is assessed based on the postoperative
visual acuity,2,5–8 but a patients’ appreciation of success
in the vision-related quality of life (QoL) often diverges
from the surgeon’s assessment.9–13 The QoL after suc-
cessful RD surgery has been assessed in six studies,4,13–17
including two reports that compared the postoperative
outcomes of patients presenting with preserved mac-
ula (macula-ON) and those with RD extending
through the macula (macula-OFF). In these articles,
there was a significant difference in the postoperative
visual acuity after macula-OFF and macula-ON RD,
but it does not manifest as a significant difference in
the QoL.14,16 Recently, Pesudovs et al18 indicated
that the instrument used to measure the QoL is not
appropriate.
In social sciences, QoL instruments are assessed for
validity (i.e., the concept to be measured is assessed by
the instrument),19,20 reliability (any significant results
obtained are repeatable),21 and responsiveness (cap-
tures changes over a period of time in participants with
modified ability during follow-up).19,20 Furthermore, a
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QoL instrument must be shown to be unidimensional
(i.e., measures only one underlying construct) and on
an interval-level scale (i.e., the periods alongside the
measurement scale should be the same sizes).21,22
Rasch analysis is a statistical transformation used to
verify these criteria23–25; thus, it plays an important
role in developing or revalidating questionnaires for
use in patients with RD.20,26
The instrument most commonly used to quantita-
tively assess the vision-related QoL is the National Eye
Institute Visual Functioning Questionnaire (NEI-VFQ-
25).15,27–33 This instrument has 25 questions and has
been used to assess the QoL in patients with various
eye-related diseases.34–37 Recently, Pesudovs et al18
performed Rasch analysis on this questionnaire and re-
ported several fundamental problems. The authors pro-
vided a reengineered NEI-VFQ-25 to redress these
problems with respect to reliability and unidimension-
ality, with better targeting of individuals.18 This work
provided two short-forms (SFs): the visual functioning
scale (SFVFS) containing six items and the socioemo-
tional scale (SFSES) containing seven items. This reen-
gineered version has been deemed the most suitable
instrument for patients with RD.18,33 Here, we assessed
the role of the modified NEI-VFQ-25 in assessing
patients with RD after successful intervention and to
analyze the preoperative and postoperative outcomes.
Methods
This study received approval from the Ethical
Committee of Canton Vaud, Switzerland (protocol
no 483/14) and was conducted in accordance with the
Declaration of Helsinki.
Patients
This observational, prospective, single-center cohort
study was performed from February 2015 to March 2017
at the Department of Vitreoretinal Surgery at Jules-
Gonin Eye Hospital. Patients with RD (macula-ON or
macula-OFF) were enrolled in the study after their first
clinical examination. Ethical approval was obtained to
include patients younger than 99 years of age and older
than 18 years of age who presented with primary RD.
We excluded all patients with RD after eye trauma, long-
lasting RD (.30 days), grade C or greater proliferative
vitreoretinopathy, or other ocular comorbidities (e.g., dia-
betic retinopathy, retinal vascular occlusions, or age-
related macular degeneration in either eye). Of 204 sub-
jects recruited for the study, the analysis included 194. A
standard clinical examination was performed in all
patients preoperatively to measure the best corrected
visual acuity (BCVA) measured as logMAR and Snellen
equivalent (SE), intraocular pressure, and axial length
measured using an IOL Master 500 (Carl Zeiss Meditec,
Dublin, CA). Each patient also underwent a fundus
examination. Spectral-domain optical coherence tomog-
raphy was performed using HEYEX software (version
1.7.1.0; Heidelberg Engineering, Heidelberg, Germany).
Patients were asked to complete the self-administered,
modified version of the validated NEI-VFQ-25
(NEI-VFQ-13) according to Nordmann’s protocol in
the French language preoperatively and at 1 (M1) and
3 months (M3) postoperatively.36
As an observational study, surgical techniques varied;
43 patients had a silicone tamponade, 41 a C3F8, 103
received SF6, and 7 underwent scleral buckling. Given
the known difference in the BCVA about the tamponade
type, we restricted the analysis to only those patients
with SF6. Nine patients (9%) were reoperated for RD,
10 (10%) withdrew or were lost to follow-up immedi-
ately after surgery, and five were lost to follow-up
before M3. In the remaining 79 patients, 47 (59%)
returned the completed questionnaire at all time points.
The questionnaire was explained in detail to the patients
by the study team, who provided assistance when
required. The participants gave the most appropriate
response. Complete questionnaire data were available
for 47 patients who attended postoperative appointments
at M1 and M3 after 23-G pars plana vitrectomy with gas
tamponade (23% SF6). Twenty-six patients had macula-
ON RD, and 21 patients had macula-OFF RD.
NEI-VFQ-13
For appropriate analysis of the NEI VFQ-13, the
modified version of the NEI-VFQ-25, the rules of Rasch
analysis were respected following Pesudovs et al18’s
explanation. As NEI-VFQ-13 is composed of two sub-
scales comprising 13 questions total (Table 1), we ana-
lyzed and report on both the composite score (CS) and
the SFVFS (six items) and SFSES (seven items) subscale
scores. Each item contained four categories.18,33
Statistical Analysis
To summarize the data obtained by the NEI-VFQ-
13, the instructions from the test manual were used.
Results were presented as the total score and a
subscales sum score. All answers to each question
were transformed into a 100-point scale, where
0 represents the worst score. The subscale scores and
CS were calculated as the mean scores for each
item.37,38 In addition, the subscale scores and the CS
were converted into Rasch scores as described
previously.18
Descriptive statistics, including mean and SD, were
used to evaluate visual acuity, age, and QoL. The CSs
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and mean QoL subscale scores were compared within
the group over time using the Wilcoxon paired test and
between macula-ON and macula-OFF groups using
the Mann–Whitney test. The correlation between the
QoL scores and the BCVA was tested in linear
regression analysis. P values were adjusted using the
Bonferroni method for multiple comparisons. P ,
0.05 was considered significant. All statistical analyses
were conducted in R software (version 3.1.3).
Results
Baseline Characteristics
The average age of the 47 patients who completed
the NEI-VFQ-13 (14 women and 33 men) was 62.45 ±
8.96 years (Table 2). We analyzed 31 right and 16 left
eyes with RD. Cataract surgery was performed previ-
ously in 20 eyes, whereas 27 eyes were phakic. We
measured an average axial length of 24.90 ± 1.71 mm.
We found no significant difference between groups
with respect to baseline characteristics, with the excep-
tion of the BCVA (P , 0.001). At baseline, the visual
acuity (median [interquartile range] logMAR) was 0.1
[0.2–0.0] (SE 20/25) among macula-ON patients and
2 [2.0–0.8] (SE 20/2000) among macula-OFF patients.
At M1, the BCVA improved to 0.1 [0.1–0.0] (SE 20/
25) among macula-ON patients and 0.3 [0.4–0.1] log-
MAR (SE 20/40) among macula-OFF patients (P =
0.01). The BCVA at M3 (final follow-up) was
0 [0.1–0.0] (SE 20/20) among macula-ON patients
and 0.1 [0.3–0.1] (SE 20/25) among macula-OFF
patients (P = 0.05, Table 2).
Quality of Life NEI-VFQ-13 Scores in Macula-ON
Versus Macula-OFF
The QoL scores varied during follow-up in both
groups. Preoperatively, the CS was 68% ± 26%, SFVFS
score was 67% ± 27%, and SFSES score was 69% ±
28% in the macula-OFF group. Quality of life scores
improved at M1 and M3 among macula-OFF patients
(Table 3). Preoperatively, among macula-ON patients,
the CS was 86% ± 17%, SFVFS score was 83% ±
15%, and SFSES score was 89% ± 19%. The QoL scores
decreased at M1, but at M3, they recovered (Table 3).
Preoperatively, a significant difference in QoL
scores (P , 0.03) was observed between the two
patient groups, with the highest sensitivity in the
SFSES score. At M1, we found no difference in
the QoL between the two groups (Tables 3 and 4).
However, 3 months after surgery, we found a
Table 1. Remediated National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) (After Performed Rash
Analysis, According to Pesudovs et al18)
Subscale 1 = short version of the
visual functioning scale (SVFVS)
Q1 At the present time, would you say your eyesight using both eyes (with
glasses or contact lenses, if you wear them) is excellent, good, poor, very
poor, or are you completely blind?
Q2 How much difficulty do you have reading ordinary print in newspapers?
Q3 How much difficulty do you have doing work or hobbies that require you to
see well up close, such as cooking, sewing, fixing things around the
house, or using hand tools?
Q4 Because of your eyesight, how much difficulty do you have finding
something on a crowded shelf?
Q5 How much difficulty do you have reading street signs or the names of
stores?
Q6 Because of your eyesight, how much difficulty do you have going down
steps, stairs, or curbs in dim light or at night?
Q7 Because of your eyesight, how much difficulty do you have visiting with
people in their homes, at parties, or in restaurants?
Subscale 2 = short version of the
socioemotional scale (SVSES)
Q1 Do you accomplish less than you would like because of your vision?
Q2 Are you limited in how long you can work or do other activities because of
your vision?
Q3 I stay home most of the time because of my eyesight.
Q4 I have much less control over what I do, because of my eyesight.
Q5 Because of my eyesight, I have to rely too much on what other people tell
me.
Q6 I worry about doing things that will embarrass myself or others because of
my eyesight
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significant difference between the two groups in re-
gard to the CS and SFSES score (P = 0.03, P =
0.002) but not the SFVFS score (P = 0.10; Tables
3 and 4).
Quality of Life NEI-VFQ-13 Scores during Follow-Up
During follow-up, QoL scores were not signifi-
cantly different in the macula-OFF group (Table 4).
An important decrease in the QoL based on the
SFSES score occurred at M1 in the macula-ON
group (P = 0.03). This change inverted from M1
to M3, with a significant progress in the QoL
regarding both the CS (P = 0.03) and SFSES (P =
0.006). This caused a slight general alteration in
QoL scores in the macula-ON group between the
preoperative measurement and M3 (P . 0.25;
Table 4).
Table 2. Baseline Characteristics and the Best Corrected Visual Acuity Pre-operatively, 1 Month (M1), and 3 Months (M3)
After Surgery in Patients With Macula-ON (ON) and Macula-OFF (OFF) RD (Wilcoxon-Paired Test)
Macula-ON Macula-OFF
Baseline characteristics
Age 62.85 ± 7.97 years 61.96 ± 10.24 years
Gender 10 women and 16 men 4 women and 17 men
Operated eye 16 right eyes and 10 left eyes 15 right eyes and 6 left eyes
Lens status 17 phakic and 9 pseudophakic 10 phakic and 11
pseudophakic
Axial length 24.76 ± 1.53 mm 25.06 ± 1.94 mm
Time Point Mean Mean
BCVA median
logMAR [IQR] (SE)
Preop 0.1 [0.2–0.0] (SE 20/25) 2 [2.0–0.8] (SE 20/2000)
Postop M1 0.1 [0.1–0.0] (SE 20/25) 0.3 [0.4–0.1] (SE 20/40)
Postop M3 0 [0.1–0.0] (SE 20/20) 0.1 [0.3–0.1] (SE 20/25)
Within group comparisons P P
Pre-op vs. M1 0.45 0.000
Pre-op vs. M3 0.18 0.000
M1 vs. M3 0.03 0.001
BCVA, best corrected visual acuity; SE, Snellen equivalent; IQR, interquartile range.
Table 3. Quality of Life Scores Preoperatively, 1 Month (M1), and 3 Months (M3) After Surgery in Patients With Macula-ON
(ON) and Macula-OFF (OFF) RD (Unpaired Two-Samples Wilcoxon Test)
Time Point
Macula-ON Macula-OFF
P (ON vs. OFF)Mean Score Mean Score
Composite score
Preop % 86% ± 17% 68% ± 26% 0.007
Postop M1 % 79% ± 21% 75% ± 17% 0.15
Postop M3 % 87% ± 19% 79% ± 17% 0.03
Subscale 1 (SFVFS)
Preop % 83% ± 15% 67% ± 27%
R 23.7 ± 1.7 22.1 ± 3.1 0.05
Postop M1 % 78% ± 20% 74% ± 16%
R 23.4 ± 2.3 23.3 ± 1.7 0.19
Postop M3 % 82% ± 20% 77% ± 17%
R 23.9 ± 2.2 23.5 ± 1.7 0.11
Subscale 2 (SFSES)
Preop % 89% ± 19% 69% ± 28%
R 1.9 ± 1.2 0.8 ± 1.6 0.002
Postop M1 % 79% ± 22% 76% ± 20%
R 1.2 ± 1.3 1.0 ± 1.4 0.30
Postop M3 % 90% ± 21% 81% ± 20%
R 2.0 ± 1.1 1.4 ± 1.2 0.01
%, the QoL score is expressed in %, where 0 represents the worst and 100 the best QoL; R, the QoL score transformed to the Rasch
scale; SFVFS, short-form visual functioning scale; SFSES, short-form socioemotional scale.
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Relationship Between Quality of Life and Best
Corrected Visual Acuity
The preoperative BCVA significantly improved
postoperatively in the macula-OFF group (P , 0.001
at both M1 and M3). Despite this change correspond-
ing to amelioration of the QoL (CS and SFSES score),
the difference was not significant. However, a signif-
icant reduction was noted in the SFSES score at M1 in
the macula-ON group, despite no change in the
BCVA. Consequently, between M1 and M3, the
BCVA significantly improved (P = 0.03), coinciding
with an important improvement on the SFSES (P =
0.006). The correlation between BCVA and QoL was
poor preoperatively (R2 , 0.20; Table 5). Postopera-
tively, in the macula-OFF group, the BCVA positively
correlated with the CS and subscale scores, with the
strongest relationship occurring at M3 in the QoL
SFSES score (P , 0.001, R2 = 0.58; Table 5). In
macula-ON patients, the BCVA did not exhibit a pos-
itive correlation with QoL scores except the SFVFS
subscale at M3 (P , 0.001, R2 = 0.41; Table 5).
Discussion
The NEI-VFQ-25 is the most widely used QoL
questionnaire, but significant limitations in its con-
struction have been identified. To redress these issues,
we used the transformation steps suggested by Pesu-
dovs et al18 to form the SFVFS and SFSES subscales.
Using these subscales, we observed an important
decrease in the QoL in patients with macula-OFF
RD compared with patients with macula-ON RD, par-
ticularly in regard to the SFSES score. Moreover,
using these less noisy instruments, we were able to
observe for the first time a negative effect of RD sur-
gery on the QoL in patients with macula-ON RD, but
this was a transient consequence because the QoL re-
turned to preoperative values by M3. Moreover, we
observed for the first time a correlation between post-
operative QoL and BCVA in both groups regarding
the CS and visual functioning subscale. However, the
socioemotional subscale correlated with the BCVA
only in macula-OFF patients, reflecting a secondary
impact of the observed vision loss.
Table 4. Comparison of Quality of Life Scores Reported by Patients With Macula-ON and Macula-OFF RD, Between Time
Points: Preoperatively, 1 Month (M1), and 3 Months (M3) After Surgery (Wilcoxon-Paired Test)
Time Point Macula-ON Macula-OFF
CS Preop vs. M1 P = 0.06 P = 0.27
Preop vs. M3 P = 0.37 P = 0.11
M1 vs. M3 P = 0.03* P = 0.18
SFVFS Preop vs. M1 P = 0.18 (0.30) P = 0.31 (0.30)
Preop vs. M3 P = 0.40 (0.32) P = 0.13 (0.13)
M1 vs. M3 P = 0.12 (0.12) P = 0.27 (0.33)
SFSES Preop vs. M1 P = 0.03* (0.02) P = 0.27 (0.40)
Preop vs. M3 P = 0.26 (0.30) P = 0.10 (0.11)
M1 vs. M3 P = 0.006** (0.006) P = 0.19 (0.16)
*P , 0.05, **P , 0.01.
CS, composite score; SFVFS, short-form visual functioning scale; SFSES, short-form socioemotional scale.
Table 5. Linear Regression Analysis to Examine the Relationship Between Quality of Life Scores and the Best Corrected
Visual Acuity at Each Time-Point During Follow-up
Time Point Macula-ON Macula-OFF
CS Preop R2 = 0.08; P = 1 R2 = 0.12; P = 1
M1 R2 = 0.06; P = 1 R2 = 0.25; P = 0.35
M3 R2 = 0.12; P = 1 R2 = 0.55; P , 0.001
SFVFS Preop R2 = 0.07; P = 1 R2 = 0.03; P = 1
M1 R2 = 0.02; P = 1 R2 = 0.16; P = 1
M3 R2 = 0.41; P = 0.007 R2 = 0.39; P = 0.05
SFSES Preop R2 = 0.08; P = 1 R2 = 0.19; P = 0.82
M1 R2 = 0.10; P = 1 R2 = 0.25; P = 0.35
M3 R2 = 0.09; P = 1 R2 = 0.58; P = 0.001
Pearson correlation coefficient and corresponding P value.
M1, month one follow-up; M3–M6, 3 to 6 months follow-up; R2, Pearson correlation coefficient value, and corresponding P value, the
Bonferroni correction was applied to adjust for the multiple tests performed; CS, composite score; SFVFS, short-form visual functioning
scale; SFSES, short-form socioemotional scale.
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The relationship between postoperative BCVA and
postoperative QoL was examined previously in
patients who underwent vitreoretinal surgery for
different disorders comprising RD.14–16,32,33,39 Our
article presents a more complete overview of the
impact of RD for the impact on patient QoL and the
relationship with the BCVA, particularly immediately
after surgery, and the visual function and socioemo-
tional subscales. Zou et al16 previously showed that
the long-term QoL (up to 3 years postoperatively)
improved alongside the BCVA after both macula-
OFF and macula-ON RD using a different QoL ques-
tionnaire. Okamoto et al14 reported significantly a bet-
ter postoperative BCVA after macula-ON than
macula-OFF RD, with no significant difference
observed in the QoL using the standard NEI-VFQ-
25. Using multivariate regression analysis, Okamoto
et al, Smretschnig et al, and Zou et al all examined
the relationship between the macular status and QoL.
However, only Zou et al observed a significant rela-
tionship, and this was present before 3 years postop-
eratively.13 Similar numbers of patients were recruited
for our study and previous studies, but the subscales
used and the homogeneity of patients for surgical pro-
cedures reduced the measurement noise such that a
significant difference in the QoL was observable
between the two RD patient groups at M1 and M3.
Significant differences between normal controls and
RD patients have been reported by Smretsching et al
using standard subscales of mental health, driving,
social functioning, general vision, and color vision.13
In contrast, regarding standard subscale findings, Oka-
moto et al reported poorer results among RD patients
for near and distance activities, dependency, mental
health, and peripheral vision.14,15 The absence of
repeatability among the results in the two studies is
most probably due to the difference in the study
groups or due to the already identified lack of subscale
validity and the recognized problems with person sep-
aration, multidimensionality, and mis-fitting items.18
The impact of decreased BCVA on reduced QoL
has been recognized as a significant risk factor, and
many ophthalmologists use BCVA to define the
functional success of surgery for RD. However, used
alone, BCVA is not a good measure for summarizing
visual function.4,30,34,40 In the literature, QoL scores
after pars plana vitrectomy in RD patients vary
between 76% and 80% in macula-OFF patients 3
months after surgery (in our study, the score was
87% in macula-ON patients at M3), reaching 89% 1
year after surgery in patients following macula-OFF
RD.13 Comparable QoL scores were tested in other
retinal diseases, including epiretinal membrane sur-
gery (79%–83%) and macular hole surgery (mean
CS 79%–82%). Very low QoL scores have been re-
ported in patients with age-related macular degenera-
tion, but were dependent on the disease stage and
activity restriction (44%–80% of days).4,41,42
This study contains several limitations, including
the small sample size and short duration of follow-up,
which limits our observations. Smretschnig et al13 re-
ported that QoL improves 3 to 12 months after sur-
gery, and Van de Put et al4 have reported a
significantly high QoL CS score 12 months after sur-
gery for macula-OFF RD. In our study, the mean CS
(79%) was similar to that reported by Smretschnig et al
(mean CS 76.3%) in patients with macula-OFF RD.
Interestingly, Van de Put et al reported a significantly
higher CS than other studies (mean 88.9%).13,43 This
finding may be an indicative of an improvement in the
QoL between 6 and 12 months postoperatively.43 The
presence of metamorphopsia and/or outer retinal folds
was identified recently as potential risk factors for
reduced QoL, but we did not assess either of these
criteria in study patients.44 In addition, how NEI-
VFQ and other similar questionnaires are targeted
may not be entirely optimal given the poor separation
of patients with good visual function/ability. During
follow-up, changes become more difficult to detect in
these patients with improvements in visual outcomes.
More than 75% of macula-OFF patients had a BCVA
of 0.3 logMAR (SE 20/40) or better by M3, indicating
that patient separation would become problematic with
longer follow-up.
The product of gain in the QoL and life expectancy
are used to calculate the gain in quality-adjusted life
years because of the intervention. Health policy
makers are increasingly relying on these types of
measures of cost effectiveness to determine reimburse-
ment models. As such, the QoL is rapidly gaining
importance in health care research. For example, Ma
et al45 demonstrated the cost effectiveness of RD sur-
gery in a geriatric population. Similarly, the differ-
ences in QoL measures between macula-ON and
macula-OFF patients in our study could also be ex-
pressed for cost-effectiveness. Given rising health care
costs, this may be necessary to maintain the emer-
gency status of macula-ON RD surgery.
Conclusion
With health care 4.0, the concept of QoL valuation
is gaining significance. Rasch analysis is recognizing
and solving existing problems in QoL instruments in a
very simple and elegant way. Here, we used a
modified NEI-VFQ-25, which uses the adjusted scale
after Rasch analysis, reportedly producing the most
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statistically robust results using this QoL instrument.
In our study, we demonstrated a significant QoL
difference between patients with macula-ON versus
macula-OFF RD. This difference was present both
preoperatively and postoperatively. Patients with
macula-OFF RD demonstrated a consistent increase
in their satisfaction throughout the recovery post-
operative period. The most pronounced QoL variations
were present in the socioemotional subscale. However,
despite anatomically successful RD surgery and good
BCVA recuperation after surgery, patients still report
postoperative visual impediments and socioemotional
limitations, which may have important consequences
for their mobility and independence.
Key words: modified version NEI-VFQ-25, quality
of life, rasch analysis, retinal detachment, vitrectomy.
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